Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wenjiong Shi"'
Autor:
Jie Zhou, Guanming Chen, Jiuling Wang, Bo Zhou, Xuemin Sun, Jinsong Wang, Shu Tang, Xiangju Xing, Xiaofei Hu, Yang Zhao, Yu Peng, Wenjiong Shi, Tingting Zhao, Yuzhang Wu, Hanbing Zhong, Ni Hong, Zhihua Ruan, Yi Zhang, Wenfei Jin
Publikováno v:
Oncogenesis, Vol 12, Iss 1, Pp 1-9 (2023)
Abstract Anti-PD-1 therapy has shown promising outcomes in the treatment of different types of cancer. It is of fundamental interest to analyze the efficacy of anti-PD-1 therapy in cancer patients infected with hepatitis B virus (HBV) since the comor
Externí odkaz:
https://doaj.org/article/a85e1700f48d4b7490586b6f4c42becf
Autor:
Jinsong Wang, Debao Li, Bo Tang, Xuemin Sun, Wenjiong Shi, Hao Li, Zhenhua Zhang, Yuzhang Wu, Yi Zhang, Qinghua Qiao
Publikováno v:
Immunity, Inflammation and Disease, Vol 11, Iss 9, Pp n/a-n/a (2023)
Abstract Background The outbreak of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has posed a great threat to human health. Some severe COVID‐19 patients still carried detectable le
Externí odkaz:
https://doaj.org/article/6852511798404a6dbd5e9908b4263e02
Autor:
Debao Li, Lei Lei, Jinsong Wang, Bo Tang, Jiuling Wang, Rui Dong, Wenjiong Shi, Guo Liu, Tingting Zhao, Yuzhang Wu, Yi Zhang
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Hepatocellular carcinoma (HCC) is a clinically and genetically heterogeneous disease. To better describe the clinical value of the main driver gene mutations of HCC, we analyzed the whole exome sequencing data of 125 patients, and combined with the m
Externí odkaz:
https://doaj.org/article/ea136f5b10754f95ba2f18acf78afee9
Autor:
Wenfei Jin, Jie Zhou, Guanming Chen, Jiuling Wang, Bo Zhou, Xuemin Sun, Jinsong Wang, Shu Tang, Xiangju Xing, Xiaofei Hu, Yang Zhao, Yu Peng, Wenjiong Shi, Tingting Zhao, Yuzhang Wu, Ni Hong, Zhihua Ruan, Yi Zhang
Anti-PD1 therapy has shown promising outcomes in different types of cancer. It is valuable to analyze whether the efficacy of anti-PD1 therapy has been impacted in cancer patients infected with hepatitis B virus (HBV) since the comorbidity of HBV and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a113be3bac02646d14ca51776a2dd62
https://doi.org/10.21203/rs.3.rs-1888416/v1
https://doi.org/10.21203/rs.3.rs-1888416/v1
